EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Lowering the Acquisition of Multidrug-Resistant Organisms (MDROs) With Pulsed-xenon (LAMP) Study: A Cluster-Randomized, Controlled, Double-Blinded, Interventional Crossover Trial

Sorabh Dhar, Chetan Jinadatha, Paul E Kilgore, Oryan Henig, George W Divine, Erika N Todter, John D Coppin, Marissa J Carter, Teena Chopra, Steve Egbert, Philip C Carling, Keith S Kaye

Clinical Infectious Diseases · 2024

DOI: 10.1093/cid/ciae240 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Sorabh Dhar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Wayne State University, School of Medicine, Detroit, Michigan, USA. Hauptthemen laut MEDLINE: Cross-Over Studies, Cross Infection, Drug Resistance, Multiple, Bacterial, Disinfection. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: AHRQ HHS, Agency for Healthcare Research and Quality, Xenex.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Environmental disinfection is essential for reducing spread of healthcare-associated infections (HAIs). Previous studies report conflicting results regarding the effects of ultraviolet (UV) light in reducing infections. This trial evaluated the impact of adding pulsed-xenon UV (PX-UV) to standard terminal cleaning in reducing environmentally implicated HAIs (eiHAIs).

Methods

The Lowering the Acquisition of MDROs with Pulsed-xenon (LAMP) trial was conducted in 2 hospitals (15 inpatient wards) utilizing a cluster-randomized, controlled, double-blinded, interventional crossover trial comparing standard terminal cleaning followed by either PX-UV (intervention arm) or sham (control arm) disinfection. The primary outcome was incidence of eiHAIs from clinical microbiology tests on the fourth day of stay or later or within 3 days after discharge from the study unit. EiHAIs included clinical cultures positive for vancomycin-resistant enterococci, extended-spectrum beta-lactamase–producing Escherichia coli or Klebsiella pneumonia, methicillin-resistant Staphylococcus aureus, and Acinetobacter baumannii, and stool polymerase chain reaction (PCR) positive for Clostridiodes difficile.

Results

Between 18 May 2017 and 7 January 2020, 25 732 patients were included, with an incidence of 601 eiHAIs and 180 954 patient-days. There was no difference in the rate of eiHAIs in the intervention and sham arms (3.49 vs 3.17 infections/1000 patient-days, respectively; RR, 1.10; 95% CI, .94–1.29; P = .23). Study results were similar when stratified by eiHAI type, hospital, and unit type.

Conclusions

The LAMP study failed to demonstrate an effect of the addition of UV light disinfection following terminal cleaning on reductions in rates of eiHAIs. Further investigations targeting hospital environmental surfaces and the role of no-touch technology to reduce HAIs are needed. Clinical Trials Registration. ClinicalTrials.gov identifier: NCT03349268; R01HS024709.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cross-Over StudiesCross InfectionDrug Resistance, Multiple, BacterialDisinfectionUltraviolet RaysHumansFemaleMaleDouble-Blind MethodMiddle AgedAgedKlebsiella pneumoniaeAdultVancomycin-Resistant EnterococciMethicillin-Resistant Staphylococcus aureusAcinetobacter baumannii

Stichwörter der Autor:innen

environmental disinfectionhospital-acquired infectioninfection controlmultidrug-resistant organisms

Autor:innen und Institutionen

  • Division of Infectious Diseases, Wayne State University, School of Medicine, Detroit, Michigan, USA.
  • Department of Internal Medicine, John D. Dingell Veterans Affairs Medical Center, Detroit, Michigan, USA.
  • Department of Medical Education, School of Medicine, Central Texas Veterans Healthcare System, Texas A&M University, Bryan, Texas, USA.
  • Department of Medicine, Central Texas Veterans Healthcare System, Temple, Texas, USA.
  • Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Department of Family Medicine and Public Health Sciences, School of Medicine, Wayne State University, Detroit, Michigan, USA.
  • Infection Prevention and Control Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Förderung

  • AHRQ HHS
  • Agency for Healthcare Research and Quality
  • Xenex

Zitieren

APA

Dhar, S., Jinadatha, C., Kilgore, P. E., Henig, O., Divine, G. W., Todter, E. N., Coppin, J. D., Carter, M. J., Chopra, T., Egbert, S., Carling, P. C., & Kaye, K. S. (2024). Lowering the Acquisition of Multidrug-Resistant Organisms (MDROs) With Pulsed-xenon (LAMP) Study: A Cluster-Randomized, Controlled, Double-Blinded, Interventional Crossover Trial. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae240

Vancouver

Dhar S, Jinadatha C, Kilgore PE, Henig O, Divine GW, Todter EN, et al. Lowering the Acquisition of Multidrug-Resistant Organisms (MDROs) With Pulsed-xenon (LAMP) Study: A Cluster-Randomized, Controlled, Double-Blinded, Interventional Crossover Trial. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciae240

BibTeX
@article{Dhar2024,
  author = {Dhar, Sorabh and Jinadatha, Chetan and Kilgore, Paul E and Henig, Oryan and Divine, George W and Todter, Erika N and Coppin, John D and Carter, Marissa J and Chopra, Teena and Egbert, Steve and Carling, Philip C and Kaye, Keith S},
  title = {Lowering the Acquisition of Multidrug-Resistant Organisms (MDROs) With Pulsed-xenon (LAMP) Study: A Cluster-Randomized, Controlled, Double-Blinded, Interventional Crossover Trial},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  doi = {10.1093/cid/ciae240}
}
Kostenlos starten →